Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age (GH-RAST)

Pfizer

Status: Completed

Conditions: Small For Gestational Age (SGA)

Treatments: Drug: growth hormone

Study type: Observational

Funder types: Industry

Identifiers

NCT01897753

A6281310

Details and patient eligibility

About

The purpose of this protocol is to retrospectively study the influence of age at start of growth hormone (GH) treatment on height gain in children born small for gestational age (SGA).

Enrollment: 264 patients

Sex: All

Ages: 4+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• SGA children.

  • Treated with GH at least 36 months.

Exclusion criteria

• Patients treated with GH for other indications (not SGA).

Trial design

264 participants in 1 patient group

Small For Gestational Age (SGA) Children

Description:

SGA children under growth hormone treatment for more than 36 months.

Treatment:

Drug: growth hormone